FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos DeCastro

Research Profile

Procedures

Anatomy

Bone Marrow

Concepts & Ideas

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Genes, fms

Co-author Network

Publications

TOP 3
Tod A Morris; David A Rizzieri; Carlos M DeCastro; Louis F Diehl; Jon P Gockerman; Anand S Lagoo; Zhiguo Li; Joseph O Moore; Arati V Rao
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia.
Mark C Lanasa; Zhiguo Li; Karen M B Matta; Joseph O Moore; Catherine W Rehder; J Brice Weinberg; Harry Cook; Michael Datto; F Joseph Daugherty; Patricia H Davis; Carlos M DeCastro; Louis F Diehl; Daphne R Friedman; Jon P Gockerman; David A Rizzieri
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Christopher A Crout; Liang-Piu Koh; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Gwynn D Long; Louis Diehl; Cristina Gasparetto; Donna Niedzwiecki; Jon Edwards; Leonard R Prosnitz; Mitchell Horwitz; Jon Chute; Ashley Morris; Patricia Davis; Anne Beaven; Nelson J Chao; Francis Ali-Osman; David A Rizzieri
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos DeCastro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tod A Morris; David A Rizzieri; Carlos M DeCastro; Louis F Diehl; Jon P Gockerman; Anand S Lagoo; Zhiguo Li; Joseph O Moore; Arati V Rao
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia.
Leukemia research 2013;37(1):28-31.
2012: Mark C Lanasa; Zhiguo Li; Karen M B Matta; Joseph O Moore; Catherine W Rehder; J Brice Weinberg; Harry Cook; Michael Datto; F Joseph Daugherty; Patricia H Davis; Carlos M DeCastro; Louis F Diehl; Daphne R Friedman; Jon P Gockerman; David A Rizzieri
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 2012;53(2):218-24.
2010: Christopher A Crout; Liang-Piu Koh; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Gwynn D Long; Louis Diehl; Cristina Gasparetto; Donna Niedzwiecki; Jon Edwards; Leonard R Prosnitz; Mitchell Horwitz; Jon Chute; Ashley Morris; Patricia Davis; Anne Beaven; Nelson J Chao; Francis Ali-Osman; David A Rizzieri
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.
Cancer investigation 2010;28(6):654-60.
2009: David A Rizzieri; Jenny A O'Brien; Gloria Broadwater; Carlos M DeCastro; Prakash Dev; Louis Diehl; Anne Beaven; Anand S Lagoo; Jon P Gockerman; Nelson J Chao; Joseph O Moore
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Cancer 2009;115(13):2922-9.
2008: Arati V Rao; Islam R Younis; Gregory J Sand; Ivan Spasojevic; David J Adams; Carlos M DeCastro; Jon P Gockerman; Bercedis L Peterson; William P Petros; Joseph O Moore; David A Rizzieri
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Leukemia & lymphoma 2008;49(8):1523-9.
2007: J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M DeCastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
American journal of hematology 2007;82(12):1063-70.
2007: David A Rizzieri; Liang-Piu Koh; Gwynn D Long; Cristina Gasparetto; Keith M Sullivan; Mitchell Horwitz; John P Chute; Clayton Smith; Jerald Z Gong; Anand S Lagoo; Donna Niedzwiecki; Jeannette M Dowell; Barbara Waters-Pick; CongXiao Liu; Dawn Marshall; James J Vredenburgh; Jon P Gockerman; Carlos M DeCastro; Joseph Moore; Nelson J Chao
Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):690-7.
2004: Jeffrey Talbot; Valerie K Ibom; David A Rizzieri; Robert Barrier; Donna Niedzwieki; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Rumbaugh; Jon P Gockerman
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.
Clinical lymphoma 2004;5(2):116-22.
2004: David A Rizzieri; Gamal Akabani; Michael R Zalutsky; R Edward Coleman; Scott D Metzler; James Bowsher; Bonnie Toaso; Elizabeth Anderson; Anand S Lagoo; Steve Clayton; Charles N Pegram; Joseph O Moore; Jon P Gockerman; Carlos M DeCastro; Cristina Gasparetto; Nelson J Chao; Darell D Bigner
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Blood 2004;104(3):642-8.
2004: David A Rizzieri; Gregory J Sand; Dean McGaughey; Joseph O Moore; Carlos M DeCastro; Nelson J Chao; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Elizabeth Anderson; Traci Foster; Bonnie Toaso; David Adams; Donna Niedzwiecki; Jon P Gockerman
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
Cancer 2004;100(11):2408-14.
2004: Jun-ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M DeCastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.
Medicine 2004;83(3):193-207.
2003: Valerie K Ibom; Robert G Prosnitz; Jerald Z Gong; Joseph O Moore; Carlos M DeCastro; Leonard R Prosnitz; David A Rizzieri; Jon P Gockerman
Rituximab in lymphocyte predominance Hodgkin's disease: a case series.
Clinical lymphoma 2003;4(2):115-8.
2003: Jeffrey Talbot; David A Rizzieri; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Brumbaugh; Jon P Gockerman
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series.
American journal of hematology 2003;73(4):295-6.
2003: Matthew Heeney; Susan M Ormsbee; M Anthony Moody; Thad A Howard; Carlos M DeCastro; Russell E Ware
Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.
Molecular genetics and metabolism 2003;78(4):291-4.
2003: David A Rizzieri; Valerie K Ibom; Joseph O Moore; Carlos M DeCastro; Gary Rosner; David J Adams; Traci Foster; Nancy Payne; Maria Thompson; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Nelson J Chao; Jon P Gockerman
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):663-8.
2002: Adam J Bass; Jon P Gockerman; Eve Hammett; Carlos M DeCastro; David J Adams; Gary Rosner; Nancy Payne; Patti Davis; Traci Foster; Joseph O Moore; David A Rizzieri
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2995-3000.
2002: Steven L McCune; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Adam J Bass; Nelson J Chao; Gwynn D Long; James J Vredenburgh; Cristina Gasparetto; David Adams; Nancy Payne; David A Rizzieri
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia & lymphoma 2002;43(5):1007-11.
2002: David A Rizzieri; Adam J Bass; Gary Rosner; Jon P Gockerman; Carlos M DeCastro; William P Petros; David J Adams; Mary J Laughlin; Patti Davis; Traci Foster; Robert Jacobson; Herbert I Hurwitz; Joseph O Moore
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):674-9.
2001: Russell E Ware; Chrisley V Pickens; Carlos M DeCastro; Thad A Howard
Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
Experimental hematology 2001;29(12):1403-9.
1997: Karen P Mann; Carlos M DeCastro; J Liu; Joseph O Moore; Sandra H Bigner; ST Traweek
Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
American journal of clinical pathology 1997;107(6):653-60.
1997: M W Wuebbens; Eric D Roush; Carlos M DeCastro; Carol A Fierke
Cloning, sequencing, and recombinant expression of the porcine inhibitor of carbonic anhydrase: a novel member of the transferrin family.
Biochemistry 1997;36(14):4327-36.
1996: D E Fleenor; S D Langdon; Carlos M DeCastro; Russel E Kaufman
Comparison of human and Xenopus GATA-2 promoters.
Gene 1996;179(2):219-23.
1996: G R Vandenbark; Y Chen; E Friday; K Pavlik; B Anthony; Carlos M DeCastro; Russel E Kaufman
Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(10):1383-92.
1994: Carlos M DeCastro; S M Denning; S Langdon; G R Vandenbark; Joanne Kurtzberg; Richard M Scearce; Barton F Haynes; Russel E Kaufman
The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
Experimental hematology 1994;22(10):1025-33.
1993: D T Bowen; Rose Ann Padua; Alan K Burnett; Carlos M DeCastro; Russel E Kaufman
Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
Leukemia 1993;7(11):1883-5.
1992: G R Vandenbark; Carlos M DeCastro; H Taylor; S Dew-Knight; Russel E Kaufman
Cloning and structural analysis of the human c-kit gene.
Oncogene 1992;7(7):1259-66.